FDA Extends PDUFA Date for Impax Parkinson’s Drug by Three Months
The FDA wants more time to review Impax Laboratories’ Parkinson’s treatment Rytary and is pushing back its decision date to Jan. 21, 2013.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.